FDA Approves First Oral GLP-1 Weight-Loss Pill, Signaling Industry Changes

TL;DR
Weight-loss drugs called GLP-1s are revolutionizing obesity treatment, with new developments including more effective medications, lower prices, and upcoming oral versions, though access remains limited due to high costs and insurance restrictions.
- Weight-Loss Drugs Are Changing. Here’s What to Know Bloomberg.com
- Weight-loss pill approval set to accelerate food industry product overhauls Reuters
- U.S. regulators approve Wegovy pill for weight loss NPR
- The FDA just approved the first GLP-1 weight-loss pill. Here’s what to know. The Washington Post
- FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss The American Journal of Managed Care® (AJMC®)
Want the full story? Read the original reporting
Read on Bloomberg.com